Myasthenia gravis is an autoimmune disorder that affects the nervous system, causing muscle weakness.
肌萎缩性侧索硬化症是一种自身免疫性疾病，影响神经系统，导致肌肉无力。
The patient's symptoms worsened significantly after she received the new medication for
myasthenia.
患者服用新药后，肌无力的症状明显加重。
Regular physical therapy helps manage
myasthenia and improve muscle strength.
定期的物理治疗有助于控制肌无力，并增强肌肉力量。
A blood test can detect antibodies associated with
myasthenia.
血液检测可以发现与肌无力相关的抗体。
Myasthenia patients often have difficulty with fine motor tasks like typing or buttoning.
肌无力患者常有执行精细动作如打字或扣纽扣时的困难。
The disease can be triggered by exposure to certain allergens in some cases of
myasthenia.
在某些肌无力病例中，接触特定过敏原会诱发疾病。
Symptoms of
myasthenia may come on gradually or suddenly, depending on the type.
肌无力的症状可能逐渐出现，也可能突然发作，这取决于类型。
A thymectomy, surgery to remove the thymus gland, can sometimes help in
myasthenia treatment.
摘除胸腺（通过胸腺切除术）有时是治疗肌无力的有效方法。
Medications like prednisone can help reduce inflammation and alleviate
myasthenia symptoms.
皮质类固醇（如泼尼松）等药物可以帮助减轻炎症，缓解肌无力症状。
Support groups and counseling can provide emotional support and coping strategies for
myasthenia patients.
支持团体和咨询可以为肌无力患者提供情感支持和应对策略。
Vyvgart (efgartigimod alfa injection) is used to treat generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes muscle weakness.
Vyvgart（efgartigimod-alfa注射液）用于治疗全身性重症肌无力（gMG），这是一种导致肌肉无力的慢性自身免疫性疾病。
Zai Lab, a Shanghai-based biopharmaceutical company, and its partner Argenx SE, a Europe-based immunology company, jointly announced that the United States Food and Drug Administration has approved Vyvgart for the treatment of generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positive.
上海生物制药公司Zai Lab及其合作伙伴欧洲免疫学公司Argenx SE联合宣布，美国食品和药物管理局已批准Vyvgart用于治疗抗乙酰胆碱受体抗体阳性的成人全身性重症肌无力。
未经许可，严禁转发。QQ交流群：688169419